Showing 1 - 5 results of 5 for search 'Ron H. N. van Schaik', query time: 0.05s Refine Results
  1. 1
    Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response

    Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response by Gloria Ravegnini, Marzia Del Re, Ambra A. Grolla, Ron H. N. van Schaik, Sabrina Angelini

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Pharmacogenetics in Psychiatry: An Update on Clinical Usability

    Pharmacogenetics in Psychiatry: An Update on Clinical Usability by Ron H. N. van Schaik, Daniel J. Müller, Daniel J. Müller, Alessandro Serretti, Magnus Ingelman-Sundberg

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients

    A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients by Kim L. W. Bunthof, Linda Al‐Hassany, Gizal Nakshbandi, Dennis A. Hesselink, Ron H. N. vanSchaik, Marc A. G. J. ten Dam, Marije C. Baas, Luuk B. Hilbrands, Teun vanGelder

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    The Clinical Implementation of Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry

    The Clinical Implementation of Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry by Jaouad Azzahhafi MD, Wout W. A. van den Broek MD, Dean R. P. P. Chan Pin Yin MD, Ankie M. Harmsze PharmD, PhD, Ron H. N. van Schaik MSc, PhD, Jurriën M. ten Berg MD, PhD

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study

    Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study by Jaouad Azzahhafi, Thomas O. Bergmeijer, Wout W. A. van den Broek, Dean R. P. P. Chan Pin Yin, Senna Rayhi, Joyce Peper, Willem L. Bor, Daniel M. F. Claassens, Daniel M. F. Claassens, Ron H. N. van Schaik, Jurriën M. ten Berg, Jurriën M. ten Berg

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: